Home / Ingredients / A / Adapalene

RetinoidPrescription-only (UK)Acne

Adapalene

Adapalene is a synthetic retinoid designed to be more stable and less irritating than tretinoin. It treats acne by keeping pores clear and calming inflammation, and it isn't broken down by benzoyl peroxide, so the two are combined in one gel. In the UK it needs a prescription.

INCI: ADAPALENE · ALSO: DIFFERIN · CAS 106685-40-9 · 2 SOURCES · CHECKED 19 NOV 2026

01

What it does, and how sure we are

UseWhat studies foundStrengthEvidence
Acne vs tretinoinIn a pooled analysis of five trials, 0.1% adapalene worked as well as 0.025% tretinoin with less irritation.10.1%Strong
Acne0.3% adapalene gel was more effective than 0.1% over 12 weeks, with similar tolerability.20.3%Moderate

Strong: several good trials agree. Moderate: at least one solid trial plus supporting work. Limited: small or company-run trials, or mostly lab studies. Very limited: little beyond lab work or claims.

02

How to use it

  1. Use once at night on the whole acne-prone area, not just spots.
  2. Expect dryness in the first weeks; moisturise and use sunscreen.
  3. Give it 12 weeks.
03

What to use it with

Works wellBenzoyl peroxideStable together; combined in prescription gels.
Space outAcidsAlternate to avoid irritation.

Check another pair

04

Side effects and safety

Usually better tolerated than tretinoin. Avoid in pregnancy.

05

Myths

“Adapalene is weaker than tretinoin so it doesn't work.”

For acne, trials found 0.1% adapalene as effective as 0.025% tretinoin.

06

Questions

Can I buy adapalene in the UK?

Not over the counter; it's prescription-only, though it's sold over the counter in the US.

07

References

  1. Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol. 1998;139 Suppl 52:48-56. PubMed
  2. Thiboutot D, Pariser DM, Egan N, et al. Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial. J Am Acad Dermatol. 2006;54(2):242-50. PubMed